CLINICAL_TRIALS trial_result · 2014-07-15

Clinical Trial Update: Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer [Phase 2]

A Phase 2 clinical trial assessed the safety and leukostimulatory activity of Panagen in patients with breast cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Panagen, Limited Liability Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-15